Content uploaded by Muhammad Hafiz Hanafi
Author content
All content in this area was uploaded by Muhammad Hafiz Hanafi on Apr 08, 2019
Content may be subject to copyright.
411
BangladeshJournalofMedicalScienceVol.18No.02April’19
Case report:
Challenges in Managing A Patient With Central Post-Stroke Pain
Mazatulfazura SF Salim1, Muhammad Haz Hana2, Tan Yew Chin3, Nur Karyatee Kassim4, Mazlina
Mazlan5
Abstract :
Objective:Thisisacaseillustrationofthechallengesinmanagingapatientwithcentralpost
strokepain secondary toright thalamic bleed.Wedescribeindetail the eventsof this case
managementandthechallengesthatwehadencountered. Method:Wereportacaseofa68-year-
oldladywhohadrightthalamicbleedsecondarytohypertensivecrisisin2015andwasfurther
complicatedwithcentralpoststrokepainoverthehemipareticside.Inourreport,wedescribein
detailthechallengesinmanagingthepatienttoimproveherfunctiontoachieveabetterquality
of life. Conclusion:Thisarticleillustratestheimportanceofamultidisciplinaryapproachand
knowledgeofvariousmethodsinmanagingapatientwithcentralpoststrokepain.
Correspondence to: Dr Muhammad Haz Hana, Senior Lecturer / Rehabilitation Medicine Specialist,
Rehabilitation Medicine Unit, School of Medical Sciences, UniversitiSainsMalaysia16150KubangKerian,
Kelantan, Malaysia. Email:drmdhaz@usm.my
Bangladesh Journal of Medical Science Vol. 18 No. 02 April’19. Page : 416-418
DOI: https://doi.org/10.3329/bjms.v18i2.40717
Case presentation:
A68-years-oldladywithuncontrolled hypertension
sustained a right thalamic bleed in 2015. She was
premorbidly well prior to the cerebrovascular
accident.Shedevelopedanacuteonsetofleftsided
hemiparesis,hemisensorylosswithneuropathicpain
overherleftupperlimb.Thepoweroftheaected
limbs were 4/5 according to Medical Research
Councilgradingscalewithevidenceofmildspasticity
overtheleftbicep,andgastrocnemius/soleusmuscle
complex with Modied Ashworth Scale of 1. She
was still able to ambulate indoor independently
usingquadripodandperformsomesimpledomestic
activities of daily living. The major problem that
aectedherdailylifewastheneuropathicpainover
theleftupperlimb.
She described the pain as burning and pricking
in nature, which was severe enough to disturb her
activitiesofdailylivingwithNumericalRatingScale
(NRS)of 7 to8over 10. The painwas continuous
throughout the day and frequently at night, which
causedserioussleepdisturbance.Thepainwasfelt
overthe entire aspect of thewhole leftupper limb
andoccasionallyspreadtoherleftfaceandneck.She
deniedanyhyperalgesiaorallodynia.
She was started on Amitryptiline 25mg daily two
weeksafter thepain onset. However,there was no
improvementintheNRSpainscoreafterstartingthe
medicationforalmostamonth.Increasingthedoseup
till50mgdailydidnotbringforthanyimprovement
1. Dr Mazatulfazura SF Salim, MBBCh BAO, MMed (Rehab Med) Lecturer / Rehabilitation Medicine
Specialist,DepartmentofMedicine,FacultyofMedicineandHealthSciences,UniversitiPutraMalaysia,
43400Serdang,Selangor,Malaysia.fazurasf@upm.edu.my
2. DrMuhammadHazHana,MBBS,MMed(Rehab Med.)SeniorLecturer/RehabilitationMedicine
Specialist,RehabilitationMedicineunit,SchoolofMedicalSciences,UniversitiSainsMalaysia,16150
KubangKerian,Kelantan,Malaysia.drmdhaz@usm.my
3. Dr Tan Yew Chin, MD, MMed (Neurosurgery) Senior Lecturer / Neurosurgeon & Pain Specialist,
DepartmentofNeurosciences,SchoolofMedical Sciences Universiti Sains Malaysia,16150Kubang
Kerian, Kelantan, Malaysia. drtanyc@usm.my
4. Dr Nur Karyatee Kassim MBBS, MPath (Chemical Pathology) Senior Lecturer/ Chemical Pathologist
Basic Sciences Unit, School of Dental Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian,
Kelantan,Malaysia.karyatee@usm.my
5. Associate Professor Dr Mazlina Mazlan, MD, MMed (Rehab Med.) Associate Professor / Rehabilitation
MedicineSpecialist.DepartmentofRehabilitationMedicine,FacultyofMedicine,UniversityofMalaya,
59100KualaLumpur,Malaysia.mazlinamazlan@ummc.edu.my
412
CentralPost-strokePain
too.Wewereabitcautiousnottoincreasethedosage
furtherasthispatienthaspre-existingcardiovascular
disease. We then stopped the Amytripiline
and changed the medication to Gabapentin, an
anticonvulsant. She only showed signicant pain
reliefwithGabapentin600mgtds,wherebyherNRS
scoreimproved to4 over 10. However, the patient
experiencedintolerablesideeectsatthisdose,where
shefelt lightheadedness andsleepyduring daytime
and was unable to perform her normal activities
of daily living. She became frustrated and started
to display depressive symptoms such as persistent
low mood and lost of interest in daily activities.
Nonethelesswedidnotstartheronanymedications,
as her PHQ-9 score was only 5, which indicated
mild depression. We then reduced the Gabapentin
dosage to 300mg tds and incorporated counseling
andpsychologicalmanagementto address thepain.
Theseinvolvedcognitivebehavioralapproachsuch
as breathing and relaxation therapy and distraction
techniques.However,these techniques require high
commitmentfromthepatienttopracticethemdaily.
WehadeducatedMadamHonthesignicantroleof
psychologicalapproachbesidesthepharmacological
managementintreatingthepainandemphasizedon
the importance of applying the technique correctly
and regularly. The managing team had failed to
convinceher topractice those techniquesregularly
eventhoughmultipletherapysessionswerearranged.
Besides, she also underwent acupuncture as an
alternativetreatmenttomanageherpain.Shestopped
afterseveralsessionsandclaimedthatitdidnothelp
torelieveherpain.HerNRSscorewasmaintained
at 6 over 10, which, according to the patient, was
notthedesirablescore.SinceGabapentinseemedto
work,wecontinuedthemedicationwithalowerdose
of300mgtds and encouragedhertocomplyonthe
breathing,relaxationanddistractiontechniques.
After 6 months of initiating treatment for the
neuropathicpain,theNRSpainscorewasstill6to
7 over 10. The patient felt dissatised and started
todeterioratein her dailyfunction.She wished for
theneuropathic pain to be completelytreated. Due
to the therapy resistance, we oered her electrical
neurostimulation therapy for further reduction of
painbutshe refused.Shehaddecidedto continue
withtheGabapentin300mgtdsonlyeventhoughit
controlsthepainsuboptimally.
Ethical Clearance:
Thiscasereportwassubmittedforpublicationafter
gettingEthicalapprovalfromtheEthicsCommittee
of the School of Medical Sciences, Universiti
Sains Malaysia, 16150 Kubang Kerian, Kelantan,
Malaysia.
Discussion:
Centralpoststrokepainbelongstoagroupofchronic
paindisordersthataretermedcentralneuropathicpain
becausethepainisduetoalesionordysfunctionof
the central nervous syste1.Neuropathicorcentralpain
hasbeen estimatedtooccurinupto8%ofpatients
aftera strokeduring 1 year follow up.About18%
of stroke patients with somatosensory disturbances
developed central post stroke pain2. In clinical
practice,the treatment ofpatientswith central post
strokepainisoftenbasedontrialanderroruntilpain
reliefisfound.Ourcasepresentedhereshowedsome
challengesinoptimizingthepain.Thereisageneral
consensusthatamitriptylineisthedrugofrstchoice,
butnotallpatientsreportaresponse3.Thetricyclic
antidepressantamitriptylinegivenat75mgdailywas
found to be eective in improving the pain scores
in10outof15patientswithcentralpoststrokepain
versus1of15inaplacebogroupofadouble-blinded
placebo-controlled study at 2 weeks and 4 weeks
from the start of treatment4.Amitriptylineisusually
startedat10 or 25mg/dayand titrated up to75mg/
day.OurpatientdidnotrespondtoAmitryptilineat
50mgdailyhoweverwedidnotincreasethedosage
furtherasourpatienthadapreexistingcardiovascular
disease.Thus,wehadtotryonanothertypeofdrug,
which is Gabapentin, the anticonvulsant group.
Although the ecacy of Gabapentin on peripheral
and central neuropathic pain is well documented.
It is associated with side-eects such as dizziness,
decreasedintellectualperformance,somnolence,and
nausea5.Thesesideeectshavecausedourpatientto
beunabletoperformherdailyactivitiesandthedose
hadtobereducedtoasub-optimaldose.
Besides medical therapy, the psychological
approachesalsoplaysimportantrole.Dierentcoping
strategies have been recommended and used for
post-strokepainsuppression.Cognitivebehavioural
therapy including breathing, relaxation and
distractiontechniquesmayhelptomodifynegative
thoughts related to pain. This can help patients to
increasetheir activitylevel andfunctioning, which
inturncanhelpimprovemood,sleepandqualityof
life.Inthecasewepresentedabove,thepatientfailed
to apply the techniques taught to her in her daily
activitiesdespitereassuranceontheeectivenessof
thepsychologicalapproach.
Acupuncture is a complementary and alternative
medical modality.The World Health Organization
(WHO) in 2002 released a report entitled
413
MazatulfazuraSFSalim,MuhammadHazHana,TanYewChin,NurKaryateeKassim,MazlinaMazlan
“Acupuncture:Review andAnalysisof Reportson
Controlled Clinical Trials”. This report states that
acupuncturecanberegardedasthemethodofchoice
fortreatingmanychronicallypainfulconditions.For
poststrokecomplications,therewereonlyevidences
on eectiveness of acupuncture for shoulder pain
after stroke6. For central post stoke pain, there are
stilllowevidencesthatacupunctureshowssignicant
eect7.In the casepresented here, acupuncturedid
nothelpinalleviatingthepain.
Other non-pharmacological treatment, including
repetitive transcranial magnetic stimulation
(rTMS), deep brain stimulation (DBS) and motor
cortex stimulation (MCS) has been reported in
case series and brief reports, but there are no
controlled trials in this eld. Due to low-quality
evidence, recommendations for MCS and DBS are
“inconclusive”inthetreatmentofcentralpoststroke
pain. Therefore, it is recommended that electrical
neurostimulation should be considered in drug-
resistantcentralpoststroke pain patients only8. We
suggested a trial of electrical neurostimulation to
our patient since she did not respond optimally to
pharmacological treatment, psychological therapy
and alternative treatment.
Inconclusion,managingcentralpoststrokepainwas
indeed very challenging and there is a great need to
identifybettertreatmentregimes. However,holistic
approach, including medical and psychological
togetherwithpatient’sparticipationandcommitment
towardstreatment oeredare theonly current best
practiceinmanagingcentralpoststrokepain.
Conict of interest: None declared
Authors’ Contributions:
Datagatheringandideaownerofthisstudy:Salim
MSF,HanaMH
Studydesign:SalimMSF,HanaMH,TanYC
Data gathering: Salim M SF, Mazlan M
Writingandsubmittingmanuscript:SalimMSF,
HanaMH
Editingandapprovalofnaldraft:SalimMSF,
HanaMH,TanYC
References:
1. Treede,R.D.,etal.,A classication of chronic pain for
ICD-11.Pain,2015.156(6):p.1003-7.
2. Andersen, G., et al., Incidence of central post-stroke
pain. Pain, 1995. 61(2):p.187-93.
3. Dworkin, R.H., et al., Pharmacologic management of
neuropathic pain: evidence-based recommendations.
Pain,2007.132(3):p.237-51.
4. Leijon, G. and J. Boivie, Central post-stroke pain--a
controlled trial of amitriptyline and carbamazepine.
Pain, 1989. 36(1):p.27-36.
5. Finnerup, N.B., et al., Algorithm for neuropathic pain
treatment: an evidence based proposal. Pain, 2005.
118(3):p.289-305.
6. Lee, J.A., et al., Acupuncture for shoulder pain after
stroke: a systematic review.JAlternComplementMed,
2012.18(9):p.818-23.
7. Mulla, S.M., et al., Management of Central Poststroke
Pain: Systematic Review of Randomized Controlled
Trials.Stroke,2015.46(10):p.2853-60.
8. Kumar, B., et al., Central poststroke pain: a review of
pathophysiology and treatment. Anesth Analg, 2009.
108(5):p.1645-57.